Napo Pharmaceuticals Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies

Chronicles entrepreneur Lisa Conte two companies, Shaman Pharmaceuticals and Napo Pharmaceuticals. The shaman was created to make the discovery and development of drugs more effective in the study of traditional, indigenous healers in the tropics. Shamans were identified promising compounds that have become known as crofelemer. For a variety of complex reasons, Shaman declared bankruptcy, and Napo, the new company Conte designed specifically for this purpose, the library bought shaman compounds including crofelemer. During the case study, Napo is developing compounds for sale in major Western markets, the organization of innovative public-private partnership to develop and distribute crofelemer in developing countries. In developing countries, the connection will treat diarrhea, which kills more than 2.5 million children every year. However, the public-private partnership has proved difficult to organize. Conte concludes with the decision to hold in the partnership, which will not only save the lives of children, but will also provide much-needed capital to keep the Napo in business. The main difficulties in establishing partnerships between sectors and complex negotiations in a complex market and regulatory environment related to the pharmaceutical industry. "Hide
by Robert Chess, Joshua Spitzer Source: Stanford Graduate School of Business 23 pages. Publication Date: September 13, 2006. Prod. #: E223-PDF-ENG